The concept of personalized toxicology is gaining traction, leveraging individual genetic and environmental profiles to predict susceptibility to toxicants. Advances in biomarker discovery and pharmacogenomics are paving the way for tailored risk assessments, ultimately contributing to more effective public health strategies and regulatory decisions.
